Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 30, 2026

Back to the front page

From X

@ActAccordingly

PAA Research on X

In the case of $GOOG, Adwords, which in my view is the greatest business model ever created is now being replaced by something quite different and considerably worse. In the case of $META, there's a long list. I don't share your view of the caliber of that business even while I recognize the considerable ad share gains they continue to get. The toxicity of the platform matters greatly if you're thinking of this business in any kind of longer term context.
@ActAccordingly

PAA Research on X

I've been short $META for a while as I mentioned in previous posts. I'm fully aware that $META has been benefitting in continued shift of ad dollars away from $GOOG (I'm also short $GOOG) as we transition away from the SEO/SEM world to AEO/GEO. However, nothing can mess up a good fundamental story like poor capital allocation and Zuck and co. have demonstrated time and time again that they're willing to pull defeat from the jaws of victory. This latest effort to go and compete with Kalshi, polymarket, and even the traditional broker/dealers to get into betting markets is just another example. Betting markets doesn't represent the existential risk to the biz like AI does, why even consider getting into this now? Based on chatter about their upcoming AI model updates, it seems CAPEX at $META is poised to go way up, yet again. Will the street like that? I guess if their latest model is Mythos quality or better, maybe it will be tolerated. Maybe, but probably not. What is it about Zuck that he feels the need to be all things to all people? Does he not understand the strengths of his own business or is he worried about the duration of those strengths? Maybe it's just ultimate hubris. Either way, at some point soon he probably pulls the reigns back as the market continues to penalize $META for the absurdities of their capital incineration.

Investor Letters

All letters

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $114B
Cestrian Capital Research 1 click

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.9T
Cestrian Capital Research 3 clicks
SAP · long

Sap Se

SAP shares are down 45% since February 2025 as AI disruption fears create a long thesis on its risk-reward.

SAP $277B
Value Investors Club 2 clicks

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $21B
WHAT ARE WE DOING? “Contrarians At The Gate” 3 clicks

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

INTC $287B
Irrational Analysis 2 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 75 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.